WHO ICTRP trial

Protein and lifestyle intervention to preserve muscle mass in obese older type 2…

NL-OMON40400 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting

Key facts

Trial ID NL-OMON40400
Public title Protein and lifestyle intervention to preserve muscle mass in obese older type 2 diabetes patients - a 13-week randomised, controlled exploratory study with a 24-week follow-up period.
Scientific title Protein and lifestyle intervention to preserve muscle mass in obese older type 2 diabetes patients - a 13-week randomised, controlled exploratory study with a 24-week follow-up period. - PROBE
Primary sponsor Nutricia
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Not Recruiting
Study type Interventional
Phase 2
Countries The Netherlands
Conditions Diabetes Mellitus type II;10018424;10003018;Diabetes Mellitus type II
Interventions Test product: A high protein oral nutritional supplement (ONS) Control product: An iso-caloric control drink with similar taste and appearance. Both products are in powder format and will be consumed after dissolving in water. Both study…
Registration date Jul 1, 2014
Target size 120
Secondary IDs NL46790.056.14;NTR4497
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations